Ronald Balassanian

Ronald Balassanian

Auto-generated profile, based on publicly available information

Ronald Balassanian

Department of Pathology University of California San Francisco California USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2016 in Cancer Cytopathology
Verified
Journal Article
Open access
PDF file
RBRonald Balassanian
Ronald Balassanian
GWGeoffrey D. Wool
Geoffrey D. Wool
JOJill C. Ono
Jill C. Ono
JOJolanta Olejnik‐Nave
Jolanta Olejnik‐Nave
MMMolinda M. Mah
Molinda M. Mah
MPMartha B. Pitman
Martha B. Pitman
BACKGROUND: Cell block (CB) techniques for fine‐needle aspiration biopsies (FNABs) vary. A direct comparison of CB techniques with statistical validation was performed to identify the best method.METHODS: Three CB techniques were compared: 1) FNAB rinsed in saline and clotted with plasma and thrombin (SPT); 2) FNAB rinsed in formalin and clotted with HistoGel (HG); and 3) FNAB rinsed in formalin, centrifuged, and the pellet captured in a collodion bag (ColB). FNAB was performed on 35 random surgical specimens for smears and each CB technique. A randomized blinded review of hematoxylin and eosin‐stained CB slides was performed and each case was scored on a scale of 1 to 3 for cellularity, preservation, and architecture and the overall best CB was identified. Significance was determined by the Mann‐Whitney U test for nonparametric ordinal data.RESULTS: The mean cellularity score was 1.71 for SPT (standard deviation [SD], 0.89), 1.68 for HG (SD, 0.67), and 3.0 for ColB (SD, 0). The mean preservation score was 1.31 for SPT (SD, 0.58), 1.54 for HG (SD, 0.70), and 2.91 for ColB (SD, 0.37). The mean architecture score was 1.45 for SPT (SD, 0.70), 1.43 for HG (SD, 0.60), and 2.71 for ColB (SD, 0.57). There was no statistical significance noted between SPT or HG when compared for each category. ColB was found to be superior to both SPT and HG when compared for each category (P<.05). The overall best CB was obtained with ColB in 33 of 35 cases (94%), with SPT proving superior in 1 of 35 cases (3%) and HG superior in 1 of 35 cases (3%).CONCLUSIONS: ColB appears to be a superior technique for CB, yielding greater cellularity, preservation, and architecture in the majority of cases. Cancer Cytopathol 2016;124:508–18. © 2016 American Cancer Society.

1 May 2020 in Cancer Research
Verified
Journal Article
Closed access
PDF file
KMKatie M. Marker
Katie M. Marker
VZValentina Zavala
Valentina Zavala
TVTatiana Vidaurre
Tatiana Vidaurre
PLPaul C. Lott
Paul C. Lott
JVJeannie Navarro Vásquez
Jeannie Navarro Vásquez
LFLaura Fejerman
Laura Fejerman
Women of Latin American origin in the United States are more likely to be diagnosed with advanced breast cancer and have a higher risk of mortality than non-Hispanic White women. Studies in U.S. Latinas and Latin American women have reported a high incidence of HER2 positive (+) tumors; however, the factors contributing to this observation are unknown. Genome-wide genotype data for 1,312 patients from the Peruvian Genetics and Genomics of Breast Cancer Study (PEGEN-BC) were used to estimate genetic ancestry. We tested the association between HER2 status and genetic ancestry using logistic and multinomial logistic regression models. Findings were replicated in 616 samples from Mexico and Colombia. Average Indigenous American (IA) ancestry differed by subtype. In multivariate models, the odds of having an HER2+ tumor increased by a factor of 1.20 with every 10% increase in IA ancestry proportion (95% CI, 1.07–1.35; P = 0.001). The association between HER2 status and IA ancestry was independently replicated in samples from Mexico and Colombia. Results suggest that the high prevalence of HER2+ tumors in Latinas could be due in part to the presence of population-specific genetic variant(s) affecting HER2 expression in breast cancer. Significance: The positive association between Indigenous American genetic ancestry and HER2+ breast cancer suggests that the high incidence of HER2+ subtypes in Latinas might be due to population and subtype-specific genetic risk variants.

1 February 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
CWChi-Heng Wu
Chi-Heng Wu
CYChen-Yen Yang
Chen-Yen Yang
LWLinlin Wang
Linlin Wang
HGHua-Xin Gao
Hua-Xin Gao
TRTaha Rakhshandehroo
Taha Rakhshandehroo
Weiyun Z. AiWeiyun Z. Ai
Weiyun Z. Ai

1 November 2020 in Journal of the American Society of Cytopathology
Verified
Journal Article
Closed access
JSJennifer L. Sauter
Jennifer L. Sauter
YCYigu Chen
Yigu Chen
DADeepu Alex
Deepu Alex
RBRonald Balassanian
Ronald Balassanian
JCJackie Cuda
Jackie Cuda
PVPaul A. VanderLaan
Paul A. VanderLaan

5 May 2023 in Journal of the American Society of Cytopathology
Verified
Journal Article
Closed access
ALAmy Ly
Amy Ly
RBRonald Balassanian
Ronald Balassanian
SASusan Alperstein
Susan Alperstein
ADAmber Donnelly
Amber Donnelly
CMCindy McGrath
Cindy McGrath
MPMartha B. Pitman
Martha B. Pitman

22 November 2019 in Cancer Cytopathology
Verified
Journal Article
Closed access
PDF file
RBRonald Balassanian
Ronald Balassanian
DNDianna L. Ng
Dianna L. Ng
AZAnnemieke van Zante
Annemieke van Zante